What is the Impact Factor of Expert Opinion on Drug Delivery?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Expert Opinion on Drug Delivery is 6.00, ranking in quartile Q1 of Web of Science (SCIE).

Is Expert Opinion on Drug Delivery indexed in Web of Science or Scopus?

Yes, Expert Opinion on Drug Delivery is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.057 (Q1) and an H-index of 152.

Who publishes Expert Opinion on Drug Delivery and what is the Article Processing Charge (APC)?

Expert Opinion on Drug Delivery is published by Taylor and Francis Ltd.. The estimated Article Processing Charge (APC) is approximately $3,353 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Expert Opinion on Drug Delivery?

The official ISO-4 abbreviation of Expert Opinion on Drug Delivery is "EXPERT OPIN DRUG DEL" with common acronym "eodd". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #4,472Top JournalReview JournalHybrid

Expert Opinion on Drug Delivery

Acronym:eodd

•

Abbreviation (ISO):EXPERT OPIN DRUG DEL

•

Identifier (ISSN):1742-5247(Print)

•

Publisher:Taylor and Francis Ltd.

Official Website Submission Portal Compare

Clarivate IF (2026)

6↑ +0.6

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Expert Opinion on Drug Delivery

WoS Q1

Annual Impact Factor Metric

Current (2026):6

Scopus SJR & RankScopus Q1

1.057

#4,472

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

152

152 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate4%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

72articles/year

5.71% Gold OA•17.09% Original Research

Aims & Scope

Expert Opinion on Drug Delivery (ISSN 1742-5247 [print], 1744-7593 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles covering all aspects of drug delivery research, from initial concept to potential therapeutic application and final relevance in clinical use. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.

Topics Covered (Recognized by AI)

MedicineBiologyChemistryMaterials SciencePharmacologyOrganic ChemistryNanotechnologyPsychologyPsychiatryGeneticsInternal MedicineEngineeringBiochemistryPhysicsChemical EngineeringBioinformaticsQuantum MechanicsPathologyImmunology

Primary Research Areas

Medicine Pharmacy

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank46/356

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank102/356

IndexSCIE

Category	Index	Rank	Quartile
PHARMACOLOGY & PHARMACY	JCRSCIE	46/356	Q1
PHARMACOLOGY & PHARMACY	JCISCIE	102/356	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF6

Articles / Year75

Total Citations80

2025

IF5.4

Articles / Year166

Total Citations957

2024

IF5

Articles / Year132

Total Citations1,524

2023

IF6.6

Articles / Year107

Total Citations2,096

2022

IF8.129

Articles / Year116

Total Citations3,117

Year	Impact Factor	Articles / Year	Total Citations
2026	6	75	80
2025	5.4	166	957
2024	5	132	1,524
2023	6.6	107	2,096
2022	8.129	116	3,117
2021	6.648	71	2,183
2020	4.838	169	7,645
2019	5.4	106	6,230
2018	5.553	78	4,795
2017	—	62	2,690
2016	—	198	12,965
2015	—	120	6,782

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,472Scopus Q1SCImago Profile

Scopus Coverage:2004-2026

•

Scopus Broad Areas:Pharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q1

1.057

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

5.94

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,353 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,242

3-Year Documents340

Citable Documents322

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

2区PHARMACOLOGY & PHARMACY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Expert Opinion on Drug Delivery (acronym: eodd, abbr: EXPERT OPIN DRUG DEL, ISSN: 1742-5247) is a peer-reviewed international scholarly journal in the field of Medicine, published by Taylor and Francis Ltd. in England since 2004. The periodical holds a Journal Impact Factor (JIF) of 6.00, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.057 (Q1), an H-index of 152.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 72 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,353 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.